| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $859.8M | +1.9% |
| Cost of Revenue | $255.0M | +1.6% |
| Gross Profit | $604.8M | +2.0% |
| R&D Expense | $190.7M | +10.1% |
| SG&A Expense | $84.9M | -1.3% |
| Operating Income | $11.6M | -67.0% |
| Pre-tax Income | $30.2M | -27.2% |
| Income Tax | $6.8M | -57.3% |
| Net Income | $23.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $246.7M | -26.3% |
| Short-term Investments | $228.0M | +21.9% |
| Current Assets | $737.3M | -6.2% |
| Total Assets | $1.73B | +4.5% |
| Current Liabilities | $575.4M | -8.7% |
| Total Liabilities | $1.57B | -3.8% |
| Stockholders' Equity | $154.7M | +773.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $153.8M | -10.4% |
| Capital Expenditures | $7.6M | +121.9% |
| Investing Cash Flow | -$209.4M | -350.2% |
| Financing Cash Flow | -$45.5M | -915.2% |
| Free Cash Flow | $146.2M | -13.1% |
| -8.4% |
| EPS (Basic) | $0.36 | -12.2% |
| EPS (Diluted) | $0.36 | -10.0% |